Skip to main content
. 2019 Apr 26;2019(4):CD004055. doi: 10.1002/14651858.CD004055.pub2

26.2. Analysis.

26.2

Comparison 26 Topical retinoids: bexarotene 1% gel versus bexarotene with corticosteroids, Outcome 2 Primary: adverse events bexarotene vs bexarotene + mometasone.